Published data at 1 year follow-up
IOP reduction, while
preventing hypotony
Reduction in anti-glaucoma
drugs for patients
Corneal endothelial
cell loss
IOP reduction, while
preventing hypotony
Reduction in anti-glaucoma
drugs for patients
Corneal endothelial
cell loss
“After numerous failed surgeries, I had an eyeWatch 2 years ago. I am finally off medications and my eye pressure has remained stable since. I am very happy with the results as I never had the need for a re-operation. “
“Titration is the holy grail for glaucoma surgery, to provide an ability to adjust flow for individual patient needs at specific postoperative time points. The eyeWatch glaucoma shunt is a major step forward in protecting from early hypotony while allowing for added IOP reduction as needed. “
PRODUCTS
FOR PHYSICIANS
FOR PATIENTS
ABOUT US
